Plain-English translation of NCT07416279 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is one of the first times this treatment has been tested in people.
Researchers are investigating whether ultrasound contrast agents—tiny bubbles called SonoVue—can measure the pressures inside your heart without needing a traditional catheter tube. This is a first-in-human study comparing the bubble method directly to the standard catheter approach during a heart procedure you're already having for your medical care.
Current methods of measuring heart pressures require inserting tubes (catheters) into blood vessels, which can be uncomfortable and carries some risk. This research could lead to a gentler, non-invasive alternative using ultrasound that might be safer and easier for patients.
You likely qualify if…
You likely don't qualify if…
On the same day as your scheduled heart catheterization procedure, researchers will inject the ultrasound contrast agent (SonoVue bubbles) and take ultrasound images while your doctor performs the standard catheter pressure measurements. All testing happens during one visit—there are no additional appointments needed. The study takes place alongside your regular care, so you won't need extra time in the hospital.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
United Kingdom